Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C

Hepatology

Volumn 28, Issue 5, 1998, Pages 1411-1415

  Lee, William M ^a   Reddy, K Rajender ^b   Tong, Myron J ^c   Black, Martin ^d   Van Leeuwen, Dirk J ^e   Hollinger, F Blaine ^f   Mullen, Kevin D ^g   Pimstone, Neville ^h   Albert, Donald ⁱ   Gardner, Sheila ⁱ  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c HUNTINGTON MEMORIAL HOSPITAL   (United States)

^d TEMPLE UNIVERSITY HOSPITAL   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g METROHEALTH MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CONSENSUS INTERFERON; INTERFERON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; KINETICS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 17344372579     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280533     Document Type: Article

References (10)

1. Davis GL, Lau JYN. Factors predictive of a beneficial response to therapy of hepatitis C. HEPATOLOGY 1997;26(Suppl):122S-127S.
2. Jenkins PJ, Cromie SL, Bowden DS, Finch CF, Dudley FJ. Chronic hepatitis C and interferon alfa therapy: predictors of long term response. MedJ Aust 1996;164:150-152.
3. Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, et al. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. HEPATOLOGY 1995;22:1351-1354.
4. Romeo R, Rumi M, Colombo M. Alpha interferon treatment of chronic hepatitis C. Biomed Pharmacother 1995;49:111-115.
5. Tong MJ, Reddy KR, Lee WM, Pockros PJ, Hoefs CJ, Keeffe EB, Hollinger FB, et al. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. HEPATOLOGY 1997;26:747-754.
6. Heathcote EJL, Keeffe EB, Lee SS, Feinman SV, Tong MJ, Reddy KR, Albert DG, et al. Re-treatment of chronic hepatitis C with consensus interferon. HEPATOLOGY 1998;27:1136-1143.
7. Tong MJ, Blatt LM, McHutchison JG, Co RL, Conrad A. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. HEPATOLOGY 1997;26:1640-1645.
8. Kakumu S, Aiyama T, Okumura A, Iwata K, Ishikawa T, Yoshioka K. Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C. J Gastroenterol Hepatol 1997;12:468-472.
9. Ampurdanes S, Olmedo E, Maluenda MD, Forns X, Lopez-Labrador FX, Costa J, Sanchez-Tapias JM, et al. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. J Hepatol 1996;25:827-832.
10. Jensen D, Shafritz D, Craig JR, Krawitt E. Nonresponders to CIFN show clinically relevant improvements in liver histology [Abstract]. Gastroenterology 1997;112:1294A.